The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: A systematic review (Evidence-based Complementary and Alternative Medicine (2007) 4, 4, (469-486) DOI: 10.1093/ecam/nel103);The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: A systematic review

Evidence-based Complementary and Alternative Medicine

Volumn 4, Issue 4, 2007, Pages 469-486

  Innes, Kim E ^a   Vincent, Heather K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Blood pressure; Cardiovascular disease; Coagulation; Glycemia; Insulin resistance; Lipids; Lung function; Oxidative stress; Sympathetic activity

Indexed keywords

CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADRENERGIC SYSTEM; ALTERNATIVE MEDICINE; BLOOD CLOTTING; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; EXERCISE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LOW FAT DIET; LUNG FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SOCIAL SUPPORT; STRESS MANAGEMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; YOGA;

EID: 38149085384     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nen008     Document Type: Erratum

References (150)

1. Rizvi AA. Type 2 diabetes: epidemiologic trends, evolving pathogenetic [corrected] concepts, and recent changes in therapeutic approach. [see comment] [erratum appears in South Med J 2005;98:4]. South Med J 2004;97:1079-87.
2. National Center for Chronic Disease Prevention and Health Promotion. National Diabetes Fact Sheet (2002). Centers for Disease Control. Available at: http://www.cdc.gov/diabetes/pubs/estimates.htm.
3. Douaihy K. Prediabetes & atherosclerosis: what's the connection? Nurse Pract 2005;30:24-35.
4. Posner B, Franz M, Quatromoni P. Nutrition and the global risk for chronic diseases: the INTERHEALTH Nutrition Initiative. Nutr Rev 1994;52:210-07.
5. Correa-Rotter R, Naicker S, Katz IJ, Agarwal SK, Herrera Valdes R, Kaseje D, et al. Demographic and epidemiologic transition in the developing world: role of albuminuria in the early diagnosis and prevention of renal and cardiovascular disease. Kidney Int Suppl 2004;92:S32-7.
6. Lerman-Garber I, Villa AR, Caballero E. Diabetes and cardiovascular disease. Is there a true Hispanic paradox? Rev Invest Clin 2004;56:282-96.
7. American Diabetes Association. American Diabetes Association: clinical practice recommendations. Diabetes Care 2004;27:S1-9.
8. Cosentino F, Assenza GE. Diabetes and inflammation. Herz 2004;29:749-59.
9. Caglayan E, Blaschke F, Takata Y, Hsueh WA. Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways. Curr Opin Pharmacol 2005;5:135-42.
10. Rennert NJ, Charney P. Preventing cardiovascular disease in diabetes and glucose intolerance: evidence and implications for care. Prim Care 2003;30:569-92.
11. McVeigh GE, Cohn JN. Endothelial dysfunction and the metabolic syndrome. Curr Diab Rep 2003;3:87-92.
12. Grundy S. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999;83:25F-9F.
13. Ginsberg H. Insulin resistance and cardiovascular disease. J Clin Invest 2000;106:453-8.
14. Isomaa B. A major health hazard: the metabolic syndrome. Life Sci 2003;73:2395-11.
15. Watkins LO. Epidemiology and burden of cardiovascular disease. Clin Cardiol 2004;27.
16. Reilly M, Rader D. The metabolic syndrome: more than the sum of its parts? Circulation 2003;108:1546-51.
17. Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 2004;59:207-23.
18. Maritim A, Sanders R, Watkins Jr. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24-38.
19. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-9.
20. Schiekofer S, Balletshofer B, Andrassy M, Bierhaus A, Nawroth PP. Endothelial dysfunction in diabetes mellitus. Semin Thromb Hemost 2000;26:503-11.
21. Stas SN, El-Atat FA, Sowers JR. Pathogenesis of hypertension in diabetes. Rev Endocr Metab Disord 2004;5:221-5.
22. Wheatcroft SB, Williams IL, Shah AM, Kearney MT. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 2003;20:255-68.
23. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 2004;47:195-203.
24. Davis WA, Knuiman M, Kendall P, Grange V, Davis TM. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2004;27:752-7.
25. Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 2004;27:2966-70.
26. Beske SD, Alvarez GE, Ballard TP, Davy KP. Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome. Am J Physiol Heart Circ Physiol 2002;282:H630-5.
27. Bjorntorp P, Holm G, Rosmond R. Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus. [see comment]. Diabet Med 1999;16:373-83.
28. Egan BM. Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep 2003;5:247-54.
29. Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 2001;14:304S-9S.
30. Palatini P. Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease. Curr Hypertens Rep 2001;3(Suppl 1):S3-9.
31. Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 2001;14:304S-9S.
32. Perin PC, Maule S, Quadri R. Sympathetic nervous system, diabetes, and hypertension. Clin Exp Hypertens 2001;23:45-55.
33. Bjorntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 1997;13:795-803.
34. Vitaliano PP, Scanlan JM, Zhang J, Savage MV, Hirsch IB, Siegler IC. A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom Med 2002;64:418-35.
35. Weber B, Schweiger U, Deuschle M, Heuser I. Major depression and impaired glucose tolerance. Exp Clin Endocrinol Diabetes 2000;108:187-90.
36. Okamura F, Tashiro A, Utumi A, Imai T, Suchi T, Tamura D, et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metab Clin Exp 2000;49:1255-60.
37. Raikkonen K, Matthews KA, Kuller LH. The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metab Clin Exp 2002;51:1573-7.
38. Chan O, Inouye K, Riddell MC, Vranic M, Matthews SG. Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinol 2003;28:87-102.
39. Nelson TL, Palmer RF, Pedersen NL, Miles TP. Psychological and behavioral predictors of body fat distribution: age and gender effects. Obes Res 1999;7:199-207.
40. Rosmond R. Stress induced disturbances of the HPA axis: a pathway to Type 2 diabetes? Med Sci Monit 2003;9:RA35-9.
41. Drapeau V, Therrien F, Richard D, Tremblay A. Is visceral obesity a physiological adaptation to stress? Panminerva Med 2003;45:189-95.
42. Chen CC, Lu FH, Wu JS, Chang CJ. Correlation between serum lipid concentrations and psychological distress. Psychiatry Res 2001;102:153-62.
43. Lucini D, Norbiato G, Clerici M, Pagani M. Hemodynamic and autonomic adjustments to real life stress conditions in humans. Hypertension 2002;39:184-8.
44. Levenstein S, Smith M, Kaplan G. Psychosocial predictors of hypertension in men and women. Arch Intern Med 2001;161:1341-6.
45. Pickering T, Clemow L, Davidson K, Gerin W. Behavioral cardiology - has its time finally arrived? Mt Sinai J Med 2003;70:101-12.
46. Davidson K, Jonas B, Dixon K, Markovitz J. Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Coronary Artery Risk Development in Young Adults. [Multicenter Study]. Arch Intern Med 2000;160:1495-500.
47. Ariyo A, Haan M, Tangen C, Rutledge J, Cushman M, Dobs A, et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation 2000;102:1773-91.
48. Spieker LE, Hurlimann D, Ruschitzka F, Corti R, Enseleit F, Shaw S, et al. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation 2002;105:2817-20.
49. Cannon RO 3rd. Role of nitric oxide in cardiovascular disease: focus on the endothelium. [erratum appears in Clin Chem 1998;44:2070]. Clin Chem 1998;44:1809-19.
50. Sherwood A, Johnson K, Blumenthal JA, Hinderliter AL. Endothelial function and hemodynamic responses during mental stress. Psychosom Med 1999;61:365-70.
51. Eaton W, Armenian H, Gallo J, Pratt L, Ford D. Depression and risk for onset of type II diabetes. A prospective population-based study. [comment]. Diabetes Care 1996;19:1097-102.
52. Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. J Psychosom Res 2002;52:1-23.
53. von Kanel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med 2001;63:531-44.
54. Goodman E, Whitaker R. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 2002;110:497-504.
55. Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complicat 2005;19:113-22.
56. Musselman D, Betan E, Larsen H, Phillips L. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003;54:317-29.
57. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. [comment]. Circulation 1999;99:2192-217.
58. Bunker SJ, Colquhoun DM, Esler MD, Hickie IB, Hunt D, Jelinek VM, et al. "Stress" and coronary heart disease: psychosocial risk factors. Med J Aust 2003;178:272-6.
59. Greenwood DC, Muir KR, Packham CJ, Madeley RJ. Coronary heart disease: a review of the role of psychosocial stress and social support. J Public Health Med 1996;18:221-31.
60. Kop WJ. The integration of cardiovascular behavioral medicine and psychoneuroimmunology: new developments based on converging research fields. Brain Behav Immun 2003;17:233-7.
61. Todaro JF, Shen BJ, Niaura R, Spiro A 3rd, Ward KD. Effect of negative emotions on frequency of coronary heart disease (The Normative Aging Study). Am J Cardiol 2003;92:901-6.
62. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002;53:897-902.
63. Everson-Rose SA, Meyer PM, Powell LH, Pandey D, Torrens JI, Kravitz HM, et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004;27:2856-62.
64. Palinkas LA, Lee PP, Barrett-Connor E. A prospective study of Type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo Study. Diabet Med 2004;21:1185-91.
65. Sahay B. Yoga and diabetes. J Assoc Physicians India 1986;34:645-8.
66. Telles S, Naveen K. Yoga for rehabilitation: an overview. Indian J Med Sci 1997;51:123-7.
67. Pandya D, Vyas V, Vyas S. Mind-body therapy in the management and prevention of coronary disease. Compr Ther 1999;25:283-93.
68. Damodaran A, Malathi A, Patil N, Shah N, Suryavansihi Marathe S. Therapeutic potential of yoga practices in modifying cardiovascular risk profile in middle aged men and women. [comment]. [Clinical Trial]. J Assoc Physicians India 2002;50:633-40.
69. Sahay B, Sahay R. Lifestyle modification in management of diabetes mellitus. J Indian Med Assoc 2002;100:178-80.
70. Garfinkel M, Schumacher HJ. Yoga. Rheum Dis Clin North Am 2000;26:125-32.
71. Chandler K. The emerging field of yoga therapy. Hawaii Med J 2001;60:286-7.
72. Raub J. Psychophysiologic effects of Hatha Yoga on musculoskeletal and cardiopulmonary function: a literature review. J Altern Complement Med 2002;8:797-812.
73. Feuerstein G. The Deeper Dimension of Yoga: Theory and Practice. Boston: Shambhala Publications, 2003.
74. Innes K, Bourguignon C, Taylor A. Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review. J Am Board Fam Pract 2005;18:491-519.
75. Labarthe D, Ayala C. Nondrug interventions in hypertension prevention and control. Cardiol Clin 2002;20:249-63.
76. Gimbel M. Yoga, meditation, and imagery: clinical applications. Nurse Pract Forum 1998;9:243-55.
77. Wood C. Mood change and perceptions of vitality: a comparison of the effects of relaxation, visualization and yoga. J R Soc Med 1993;86:254-8.
78. Miller J, Fletcher K, Kabat-Zinn J. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry 1995;17:192-200.
79. Manchanda S, Narang R, Reddy K, Sachdeva U, Prabhakaran D, Dharmanand S, et al. Retardation of coronary atherosclerosis with yoga lifestyle intervention. [Randomized Controlled Trial]. J Assoc Physicians India 2000;48:687-94.
80. Patel C, Marmot M, Terry D, Carruthers M, Hunt B, Patel M. Trial of relaxation in reducing coronary risk: four year follow-up. Br Med J 1985;290:1103-6.
81. Jayasinghe SR. Yoga in cardiac health (a review). Eur J Cardiovasc Prev Rehabil 2004;11:369-75.
82. Innes KE, Bourguignon C, Taylor AG. Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review. J Am Board Fam Pract 2005;18:491-519.
83. Singh S, Malhotra V, Singh KP, Madhu SV, Tandon OP. Role of yoga in modifying certain cardiovascular functions in type 2 diabetic patients. J Assoc Physicians India 2004;52:203-6.
84. Kerr D, Gillam E, Ryder J, Trowbridge S, Cavan D, Thomas P. An Eastern art form for a Western disease: randomised controlled trial of yoga in patients with poorly controlled insulin-treated diabetes. Pract Diabetes Intern 2002;19:164-6.
85. Elder C. Ayurveda for diabetes mellitus: a review of the biomedical literature. Altern Ther Health Med 2004;10:44-50.
86. Wang C, Collet JP, Lau J. The effect of Tai Chi on health outcomes in patients with chronic conditions: a systematic review. Arch Intern Med 2004;164:493-501.
87. Verhagen AP, Immink M, van der Meulen A, Bierma-Zeinstra SM. The efficacy of Tai Chi Chuan in older adults: a systematic review. Fam Pract 2004;21:107-13.
88. Bijlani RL, Vempati RP, Yadav RK, Ray RB, Gupta V, Sharma R, et al. A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus. J Altern Complement Med 2005;11:267-74.
89. Yogendra J, Yogendra H, Ambardekar S, Leie R, Shetty S, Dave M, et al. Beneficial effects of yoga lifestyle on reversibility of ischaemic heart disease: Caring Heart Project of International Board of Yoga. JAPI 2004;52:283-9.
90. Fields JZ, Walton KG, Schneider RH, Nidich S, Pomerantz R, Suchdev P, et al. Effect of a multimodality natural medicine program on carotid atherosclerosis in older subjects: a pilot trial of Maharishi Vedic Medicine. Am J Cardiol 2002;89:952-8.
91. Sahay B. Yoga and diabetes. J Assoc Physicians India 1986;34:645-8.
92. Divekar M, Bhat M, Mulla A. Effect of yoga therapy in diabetes and obesity. J Diabet Assoc India 1978;17:75-8.
93. Shembakar A, Kate S. Yogic exercise in the management of diabetes mellitus. J Diabet Assoc India 1980;20:167-71.
94. Gore M. Yogic treatment for diabetes. Yoga Mimamsa 1988;26:130-45.
95. Mukherjee A, Bandyopadhyay S, Benerjee S, Maity A. The influence of yogic exercise on blood sugar level in normal and diabetic volunteers. Indian J Physiol Allied Sci 1989;43:105-12.
96. Mukherjee A, Banerjee S, Bandyopadhyay S, Mukherjee P. Studies on the interrelationship between insulin tolerance and yoga. Indian J Physiol Allied Sci 1992;46:110-5.
97. Singh S, Malhotra V, Singh K, Sharma S. A preliminary report on the role of yoga asanas on oxidative stress in non-insulin dependent diabetes. Indian J Clin Biochem 2001;16:216-20.
98. Malhotra V, Singh S, Singh K, Gupta P, Sharma S, Madhu S, et al. Study of yoga asanas in assessment of pulmonary function in NIDDM patients. Indian J Physiol Pharmacol 2002;46:313-20.
99. Jain S, Uppal A, Bhatnagar S, Talukdar B. A study of response pattern of non-insulin dependent diabetics to yoga therapy. Diabetes Res Clin Pract 1993;19:69-74.
100. Jain S, Talukdar B. Role of yoga in control of hyperglycemia in middle aged patients of non-insulin dependent diabetes mellitus. Indian J Clin Biochem 1995;10:62-5.
101. Monro R, Power J, Coumar A, Dandona P. Yoga therapy for NIDDM: a controlled trial. Complement Med Res 1992;6:66-8.
102. Khare K, Jain D. Effect of yoga on plasma glucose and serum fructosamine level in NIDDM. Yoga Mimamsa 1999;33:1-9.
103. Malhotra V, Singh S, Tandon O, Madhu S, Prasad A, Sharma S. Effect of Yoga asanas on nerve conduction in type 2 diabetes. Indian J Physiol Pharmacol 2002;46:298-306.
104. Yogendra J, Yogendra H, Ambardekar S, Leie R, Shetty S, Dave M, et al. Beneficial effects of yoga lifestyle on reversbility of ischaemic heart disease: Caring Heart Project of International Board of Yoga. J Assoc Physicians India 2004;52:283-9.
105. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, et al. Intensive lifestyle changes for reversal of coronary heart disease. [see comment] [erratum appears in JAMA 1999;281:1380]. JAMA 1998;280:2001-7.
106. Koertge J, Weidner G, Elliott-Eller M, Scherwitz L, Merritt-Worden TA, Marlin R, et al. Improvement in medical risk factors and quality of life in women and men with coronary artery disease in the Multicenter Lifestyle Demonstration Project. Am J Cardiol 2003;91:1316-22.
107. Khare K, Rai S. Study of lipid profile in post myocardial infarction subjects following yogic lifestyle intervention. Indian Pract 2002;55:369-73.
108. Sahay BK, Sadasivudu B, Yogi R, Bhaskaracharyulu C, Raju PS, Madhavi S, et al. Biochemical parameters in normal volunteers before and after yogic practices. Indian J Med Res 1982;76(Suppl):144-8.
109. Bhaskaracharyulu C, Sitarama Raju P, Girija Kumari D, Sahay B, Annapurna M, Madhavi S, et al. The effect of yoga on lipo protein profile in diabetics. J Diabetes Assoc India 1986;26:120-4.
110. Naruka J, Mathur R, Mathur A. Effect of pranayama practices on fasting blood glucose and serum cholesterol. Indian J Med Sci 1986;40:149-52.
111. Schmidt T, Wijga A, Von Zur Muhlen A, Brabant G, Wagner T. Changes in cardiovascular risk factors and hormones during a comprehensive residential three month kriya yoga training and vegetarian nutrition. [Clinical Trial]. Acta Physiol Scand Suppl 1997;640:158-62.
112. Schmidt T, Wijga A, Von Zur Muhlen A, Brabant G, Wagner T. Changes in cardiovascular risk factors and hormones during a comprehensive residential three month kriya yoga training and vegetarian nutrition. Acta Physiol Scand Suppl 1997;640:158-62.
113. Ornish D. Avoiding revascularization with lifestyle changes: The Multicenter Lifestyle Demonstration Project. Am J Cardiol 1998;82:26.
114. Chohan IS, Nayar HS, Thomas P, Geetha NS. Influence of yoga on blood coagulation. Thromb Haemost 1984;51:196-7.
115. Yadav RK, Ray RB, Vempati R, Bijlani RL. Effect of a comprehensive yoga-based lifestyle modification program on lipid peroxidation. Indian J Physiol Pharmacol 2005;49:358-62.
116. Sharma H, Sen S, Singh A, Bhardwaj NK, Kochupillai V, Singh N. Sudarshan Kriya practitioners exhibit better antioxidant status and lower blood lactate levels. Biol Psychol 2003;63:281-91.
117. Jatuporn S, Sangwatanaroj S, Saengsiri A, Rattanapruks S, Srimahachota S, Uthayachalerm W, et al. Short-term effects of an intensive lifestyle modification program on lipid peroxidation and antioxidant systems in patients with coronary artery disease. Clin Hemorheol Microcirc 2003;29:429-36.
118. Bhattacharya S, Pandey U, Verma N. Improvement in oxidative status with yogic breathing in young healthy males. Indian J Physiol Pharmacol 2002;46:349-54.
119. Dhalla N, Temsah R, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000;18:655-73.
120. Lee KU. Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract 2001;54(Suppl 2):S29-33.
121. Juhan-Vague I, Morange PE, Alessi MC. The insulin resistance syndrome: implications for thrombosis and cardiovascular disease. Pathophysiol Haemost Thromb 2002;32:269-73.
122. Ginsberg HN, Huang LS. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovasc Risk 2000;7:325-31.
123. Kohler HP. Insulin resistance syndrome: interaction with coagulation and fibrinolysis. Swiss Med Wkly 2002;132:241-52.
124. McKeever TM, Weston PJ, Hubbard R, Fogarty A. Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2005;161:546-56.
125. Tran MD, Holly RG, Lashbrook J, Amsterdam EA. Effects of hatha yoga practice on the health-related aspects of physical fitness. Prev Cardiol 2001;4:165-70.
126. Telles S, Nagarathna R, Nagendra HR, Desiraju T. Physiological changes in sports teachers following 3 months of training in Yoga. Indian J Med Sci 1993;47:235-8.
127. Joshi L, Joshi V, Gokhale L. Effect of short term 'Pranayam' practice on breathing rate and ventilatory functions of lung. Indian J Physiol Pharmacol 1992;36:105-8.
128. Harinath K, Malhotra AS, Pal K, Prasad R, Kumar R, Kain TC, et al. Effects of Hatha yoga and Omkar meditation on cardiorespiratory performance, psychologic profile, and melatonin secretion. J Altern Complement Med 2004;10:261-8.
129. Birkel DA, Edgren L. Hatha yoga: improved vital capacity of college students. Altern Ther Health Med 2000;6:55-63.
130. Berger B, Owen D. Mood alteration with yoga and swimming: aerobic exercise may not be necessary. Percept Mot Skills 1992;75(3 Pt 2):1331-43.
131. Malathi A, Damodaran A, Shah N, Patil N, Maratha S. Effect of yogic practices on subjective well being. [Clinical Trial]. Indian J Physiol Pharmacol 2000;44:202-6.
132. Ray U, Mukhopadhyaya S, Purkayastha S, Asnani V, Tomer O, Prashad R, et al. Effect of yogic exercises on physical and mental health of young fellowship course trainees. [Randomized Controlled Trial]. Indian J Physiol Pharmacol 2001;45:37-53.
133. Schell F, Allolio B, Schonecke O. Physiological and psychological effects of Hatha-Yoga exercise in healthy women. [Clinical Trial. Controlled Clinical Trial. Journal Article]. Int J Psychosom 1994;41:46-52.
134. Sahajpal P, Ralte R. Impact of induced yogic relaxation training (IYRT) on stress-level, self-concept and quality of sleep among minority group individuals. J Indian Psychol 2000;18:66-73.
135. Lavey R, Sherman T, Mueser KT, Osborne DD, Currier M, Wolfe R. The effects of yoga on mood in psychiatric inpatients. Psychiatr Rehabil J 2005;28:399-402.
136. Janakiramaiah N, Gangadhar B, Naga Venkatesha Murthy P, Harish M, Subbakrishna D, Vedamurthachar A. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramine. J Affect Disord 2000;57:255-9.
137. Nespor K. Twelve years of experience with yoga in psychiatry. Int J Psychosom 1993;40:105-7.
138. Shannahoff-Khalsa DS, Ray LE, Levine S, Gallen CC, Schwartz BJ, Sidorowich JJ. Randomized controlled trial of yogic meditation techniques for patients with obsessive compulsive disorders. CNS Spectr Intern J Neuropsychiatric Med 1999;4:34-46.
139. Cohen L, Warneke C, Fouladi RT, Rodriguez MA, Chaoul-Reich A. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 2004;100:2253-60.
140. Mishra M, Sinha RK. Effect of yogic practices on depression and anxiety. J Project Psychol Mental Health 2001;8:23-7.
141. Woolery A MH, Sternlieb B, Zeltzer L. A yoga intervention for young adults with elevated symptoms of depression. Altern Ther Health Med 2004;10:60-3.
142. Jorm A, Christensen H, Griffiths K, Rodgers B. Effectiveness of complementary and self-help treatments for depression. Med J Aust 2002;176(Suppl):S84-96.
143. Latha, Kaliappan K. Yoga, pranayama, thermal biofeedback techniques in the management of stress and high blood pressure. J Indian Psychol 1991;9:36-46.
144. Walia IJ, Mehra P, Grover P, Earnest C, Verma SK. Sanjeev Health status of nurses and yoga. IV. Experiment and results. Nurs J India 1992;83:27-8.
145. Ernst E, Rand J, Stevinson C. Complementary therapies for depression: an overview. Arch Gen Psychiatry 1998;55:1026-32.
146. Innes K, Vincent H, Taylor A. Chronic stress and insulin-resistance- related indices of cardiovascular disease risk: Part II. A potential role for mind-body therapies. Altern Ther Health Med 2006; in press.
147. Innes K, Vincent H, Taylor A. Chronic stress and insulin-resistance- related indices of cardiovascular disease risk: Part I. Neurophysiologic responses and pathologic sequellae. Altern Ther Health Med 2006; in press.
148. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918.
149. Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database Syst Rev 2005;2: CD005270.
150. Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998;19:159-66.